Evaluation of CITED1, SIX1, and CD56 Protein Expression for Identification of Blastemal Elements in Wilms Tumor.

Summary, in English

Successful further treatment of Wilms tumors (WTs) after preoperative chemotherapy and surgery depends on correct histopathologic risk stratification, including quantification of remaining blastemal elements. In the present study, we assessed the usefulness of protein markers for the detection of WT blastema.

• Author: Daniel Sehic; Cristina Ciornei; David Gisselsson Nord
• Department/s: Division of Clinical Genetics; Nephrology; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
• Publishing year: 2014
• Language: English
• Pages: 828-833
• Publication/Series: American Journal of Clinical Pathology
• Volume: 141
• Issue: 6
• Links: http://www.ncbi.nlm.nih.gov/pubmed/24838327?dopt=Abstract; http://dx.doi.org/10.1309/AJCPQ8Q0YTHSYZTX
• Document type: Journal article
• Publisher: Oxford University Press
• Topic: Medical Genetics; Urology and Nephrology
• Status: Published
• ISBN/ISSN/Other: ISSN: 1943-7722